Viewing Study NCT02143635


Ignite Creation Date: 2025-12-24 @ 10:03 PM
Ignite Modification Date: 2025-12-25 @ 7:39 PM
Study NCT ID: NCT02143635
Status: COMPLETED
Last Update Posted: 2021-05-21
First Post: 2014-05-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module